Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

About this score

  • In the top 5% of all articles scored by Altmetric
  • One of the highest-scoring articles from this source (#10 of 1,835)
  • High score compared to articles of the same age (95th percentile)
  • High score compared to articles of the same age and source (99th percentile)

Mentioned by

blogs
1 blog
twitter
20 tweeters
facebook
2 Facebook pages

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this scholarly content. Click here to find out more.
Article title
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-603
Pubmed ID
Authors

Pérol D, Provençal J, Hardy-Bessard AC, Coeffic D, Jacquin JP, Agostini C, Bachelot T, Guastalla JP, Pivot X, Martin JP, Bajard A, Ray-Coquard I

Abstract

Chemotherapy induced nausea and vomiting (CINV) remains a major problem that seriously impairs the quality of life (QoL) in cancer patients receiving chemotherapy regimens. Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. A randomized, placebo-controlled Phase III study was conducted to evaluate the efficacy of a complex homeopathic medicine, Cocculine, in the control of CINV in non-metastatic breast cancer patients treated by standard chemotherapy regimens.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this article. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this article. Click here to see the article's page on the Mendeley website.

Geographical breakdown

Country Count As %
United States 1 8%
Unknown 11 92%

Demographic breakdown

Readers by professional status Count As %
Researcher (at an Academic Institution) 4 33%
Student (Bachelor) 3 25%
Student (Master) 2 17%
Other Professional 1 8%
Librarian 1 8%
Other 1 8%
Readers by discipline Count As %
Medicine 8 67%
Biological Sciences 3 25%
Psychology 1 8%

Score in context

This article has an Altmetric score of 22.85. This is our high-level measure of the quality and quantity of online attention that this article has received. This score was calculated when the article was last mentioned on 29 October 2014.
All articles
#117,513
of 3,696,029 articles
Articles in BMC Cancer
#10
of 1,835 articles
Articles of similar age
#12,800
of 281,497 articles
Articles of similar age in BMC Cancer
#1
of 101 articles
Altmetric has tracked 3,696,029 articles across all sources so far. Compared to these this article has done particularly well and is in the 96th percentile: it's in the top 5% of all articles ever tracked by Altmetric.
So far Altmetric has tracked 1,835 articles from this source. They typically receive a little less attention than average, with a mean score of 2.6. This article has done particularly well, scoring higher than 99% of its peers.
Older articles will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this score to the 281,497 tracked articles that were published within six weeks on either side of this one in any source. This article has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this article to 101 articles from the same source and published within six weeks on either side of this one. This article has done particularly well, scoring higher than 99% of its contemporaries.